ArticleInternational journal of molecular sciences2026
SurroDock: A Deep Learning Surrogate for Accelerated Pre-Docking Ligand Prioritization in Structure-Based Virtual Screening.
Article in International journal of molecular sciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
1 author.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The rapid expansion of make-on-demand and public chemical libraries has made exhaustive docking-based structure-based virtual screening increasingly difficult. This study introduces SurroDock, a lightweight deep-learning surrogate designed to approximate AutoDock Vina docking scores from low-cost two-dimensional molecular features, serving as a practical pre-filter for docking. SurroDock was evaluated for estrogen receptor alpha using two distinct conformations: an agonist-bound (PDB ID: 1GWR) and an antagonist/SERM-bound (PDB ID: 3ERT). The dataset comprised approximately 334,000 unique compounds curated from the NCI Open Database, PubChem, and BindingDB, all docked using a standardized AutoDock Vina workflow. The model was trained on concatenated 2D molecular representations comprising Morgan fingerprints, MACCS keys, RDKit physicochemical descriptors, Vina-inspired ligand descriptors, atom-pair fingerprints, and 2D pharmacophore fingerprints. The docking-score distributions differed substantially between receptor states, with 3ERT exhibiting more favorable scores than 1GWR and weak inter-state score correlation supporting state-specific modeling. Using the integrated Unified-200k training set (200,000 compounds randomly sampled per receptor from the three docked sources), SurroDock achieved strong held-out validation performance, with
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.